Skip to main content
. 2017 May 28;2017:8178643. doi: 10.1155/2017/8178643

Figure 1.

Figure 1

(a) The MSCs-EP2 were positive for CD73, CD90, and CD105 and negative for CD45. (b) Overexpression of EP2 does not impact MSCs osteogenic differentiation capability. (c) Transwell assay demonstrated that EP2 overexpression does not affect MSC migration, P > 0.05 (MSC versus MSC-EP2).